cephalexin has been researched along with rifampin in 33 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (33.33) | 18.7374 |
| 1990's | 4 (12.12) | 18.2507 |
| 2000's | 11 (33.33) | 29.6817 |
| 2010's | 5 (15.15) | 24.3611 |
| 2020's | 2 (6.06) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Benet, LZ; Brouwer, KL; Chu, X; Dahlin, A; Evers, R; Fischer, V; Giacomini, KM; Hillgren, KM; Hoffmaster, KA; Huang, SM; Ishikawa, T; Keppler, D; Kim, RB; Lee, CA; Niemi, M; Polli, JW; Sugiyama, Y; Swaan, PW; Tweedie, DJ; Ware, JA; Wright, SH; Yee, SW; Zamek-Gliszczynski, MJ; Zhang, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Aubé, J; Ballinger, E; Dartois, V; Gold, B; Hanson, P; Ling, Y; Little, D; Lopez Quezada, L; Mitscher, LA; Nathan, C; Nguyen, Q; Pingle, M; Porubsky, P; Roberts, J; Rogers, S; Schoenen, FJ; Smith, R; Somersan, S; Warrier, T; Zhang, D; Zimmerman, M | 1 |
| Chang, L; Feng, LS; Gao, C; Lv, ZS; Ren, QC; Xu, Z; Zhang, S | 1 |
| Agrahari, AK; Rajkhowa, S; Sharma, A; Tiwari, VK | 1 |
| Benfodda, Z; Duvauchelle, V; Meffre, P | 1 |
| Emerson, BB; Harding, AL; Smith, AL; Smith, DH | 1 |
| Hossack, G; Paddock, G; Parsons, RL | 1 |
| Doern, GV; Jorgensen, JH; Maher, LA; Preston, DA; Redding, JS; Thornsberry, C; Tubert, T | 1 |
| Neu, HC | 1 |
| Fillastre, JP | 1 |
| Klastersky, J | 1 |
| Bullock, WE | 1 |
| Kabat, K; Melick, C; Yogev, R | 1 |
| Ginsburg, CM; McCracken, GH | 1 |
| Auger, P; Dyrda, I; Gagnon, G; Laaban, JP; Marquis, G; Meere, C; Montplaisir, S | 1 |
| Corwin, RW; Francis, JB; Hand, WL; Johnson, JD; King-Thompson, N | 1 |
| Feder, HM; Hoss, DM | 1 |
| Feder, HM; Pond, KE | 1 |
| Harrington, EW; Trun, NJ | 1 |
| Gizatullina, ED; Guryleva, ME; Ozol, SM; Vizel', AA | 1 |
| Chadwick, EG; Das, L; Gavin, PJ; Yogev, R | 1 |
| Crooke, E; Li, Z; Skarstad, K; Zheng, W | 1 |
| Bahloul, A; Boubrik, F; Rouviere-Yaniv, J | 1 |
| Egan, ES; Løbner-Olesen, A; Waldor, MK | 1 |
| Kukureka, AV; Lazarev, AL; Prokopenko, LG; Siplivaia, LE; Siplivyĭ, GV | 1 |
6 review(s) available for cephalexin and rifampin
| Article | Year |
|---|---|
Membrane transporters in drug development.
Topics: Animals; Computer Simulation; Decision Trees; Drug Approval; Drug Discovery; Drug Evaluation, Preclinical; Drug Interactions; Humans; Membrane Transport Proteins; Mice; Mice, Knockout; Prescription Drugs | 2010 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Triazole derivatives and their anti-tubercular activity.
Topics: Antitubercular Agents; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship; Triazoles; Tuberculosis | 2017 |
Emerging impact of triazoles as anti-tubercular agent.
Topics: Antitubercular Agents; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Structure-Activity Relationship; Triazoles; Tuberculosis | 2022 |
Recent contribution of medicinally active 2-aminothiophenes: A privileged scaffold for drug discovery.
Topics: Antifungal Agents; Chemistry, Pharmaceutical; Drug Discovery; Structure-Activity Relationship; Thiophenes | 2022 |
Newer antibiotics.
Topics: Anti-Bacterial Agents; Bacterial Infections; Carbenicillin; Cephalexin; Cephaloglycin; Clindamycin; Doxycycline; Gentamicins; Humans; Imidazoles; Indenes; Minocycline; Penicillin Resistance; Penicillins; Rifampin; Spectinomycin | 1973 |
27 other study(ies) available for cephalexin and rifampin
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Novel Cephalosporins Selectively Active on Nonreplicating Mycobacterium tuberculosis.
Topics: Animals; Antitubercular Agents; Cells, Cultured; Cephalosporins; Female; Hep G2 Cells; Humans; Macrophages; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Microsomes, Liver; Mycobacterium tuberculosis; Structure-Activity Relationship; Tuberculosis | 2016 |
Hemophilus influenzae type B susceptibility to 17 antibiotics.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Cefazolin; Cephalexin; Cephaloridine; Cephalothin; Cephradine; Chloramphenicol; Clindamycin; Culture Media; Erythromycin; Gentamicins; Haemophilus influenzae; Kanamycin; Penicillin G; Penicillin Resistance; Rifampin; Tetracycline | 1975 |
The absorption of antibiotics in adult patients with coeliac disease.
Topics: Adult; Amoxicillin; Ampicillin; Anti-Bacterial Agents; Celiac Disease; Cephalexin; Clindamycin; Erythromycin; Ethics, Medical; Fusidic Acid; Humans; Intestinal Absorption; Lincomycin; Pivampicillin; Rifampin; Sulfamethoxazole; Trimethoprim | 1975 |
National collaborative study of the prevalence of antimicrobial resistance among clinical isolates of Haemophilus influenzae.
Topics: Ampicillin Resistance; Anti-Bacterial Agents; beta-Lactamases; Cefaclor; Cefamandole; Cephalexin; Cephalothin; Chloramphenicol Resistance; Drug Combinations; Drug Resistance, Microbial; Erythromycin; Haemophilus influenzae; Humans; Rifampin; Sulfamethoxazole; Tetracycline Resistance; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; United States | 1988 |
[Tubulointerstitial nephropathies due to antibiotics].
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Cephalexin; Cephaloridine; Cephalothin; Drug Hypersensitivity; Gentamicins; Humans; Kanamycin; Kidney Diseases; Kidney Tubules; Nephritis; Nephritis, Interstitial; Penicillins; Polyenes; Polymyxins; Rifampin | 1973 |
[Recent acquisitions in antibiotic therapy].
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbenicillin; Cephalexin; Clindamycin; Doxycycline; Gentamicins; Microbial Sensitivity Tests; Minocycline; Rifampin; Sulfamethoxazole; Tetracycline; Trimethoprim | 1973 |
The newer antibiotics: some therapeutic considerations.
Topics: Anti-Bacterial Agents; Bacterial Infections; Carbenicillin; Cephalexin; Cephaloglycin; Cephalosporins; Enterobacteriaceae Infections; Gentamicins; Humans; Pseudomonas Infections; Rifampin; Staphylococcal Infections | 1972 |
Nasopharyngeal carriage of Haemophilus influenzae type b: attempted eradication by cefaclor or rifampin.
Topics: Adult; Carrier State; Cefaclor; Cephalexin; Child; Child Day Care Centers; Child, Preschool; Evaluation Studies as Topic; Family; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Meningitis, Haemophilus; Nasopharynx; Rifampin | 1981 |
Comparison of salivary concentrations of rifampin and cefaclor: a rationale for chemoprophylaxis of Hemophilus influenzae type b disease.
Topics: Adult; Cefaclor; Cephalexin; Drug Evaluation; Haemophilus Infections; Haemophilus influenzae; Humans; Male; Microbiological Techniques; Middle Aged; Rifampin; Saliva; Suspensions; Tablets; Time Factors | 1982 |
Rifampin therapy for Staphylococcus epidermidis endocarditis.
Topics: Cephalexin; Cephalothin; Clindamycin; Cloxacillin; Endocarditis, Bacterial; Gentamicins; Humans; Male; Middle Aged; Rifampin; Staphylococcal Infections | 1982 |
Antibiotic uptake by alveolar macrophages.
Topics: Animals; Anti-Bacterial Agents; Cefamandole; Cefazolin; Cephalexin; Clindamycin; Macrophages; Male; Penicillin G; Pulmonary Alveoli; Rabbits; Rifampin | 1980 |
Addition of rifampin to conventional therapy for recurrent furunculosis.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Cephalexin; Chlorhexidine; Cloxacillin; Drug Therapy, Combination; Furunculosis; Humans; Male; Mupirocin; Recurrence; Rifampin | 1995 |
Addition of rifampin to cephalexin therapy for recalcitrant staphylococcal skin infections--an observation.
Topics: Cephalexin; Chickenpox; Child; Drug Therapy, Combination; Hand Dermatoses; Humans; Impetigo; Male; Prospective Studies; Rifampin; Skin Diseases, Infectious; Skin Diseases, Vesiculobullous; Staphylococcal Infections; Wound Infection | 1996 |
Unfolding of the bacterial nucleoid both in vivo and in vitro as a result of exposure to camphor.
Topics: Camphor; Cell Division; Cephalexin; Chloramphenicol; Chromosomes, Bacterial; Escherichia coli; Fluorouracil; Microscopy, Fluorescence; Protein Synthesis Inhibitors; Rifampin; Temperature | 1997 |
[Antibiotic sensitivity of pathogenic microflora: data of the bacteriological laboratory at the antituberculosis clinic].
Topics: Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Antibiotics, Antitubercular; Bacteria; Carbenicillin; Cefuroxime; Cephalexin; Cephalosporins; Chloramphenicol; Ciprofloxacin; Doxycycline; Drug Therapy, Combination; Erythromycin; Female; Gentamicins; Humans; Inpatients; Lincomycin; Male; Microbial Sensitivity Tests; Neomycin; Outpatients; Oxacillin; Penicillins; Rifampin; Spiramycin; Streptomycin; Tetracycline | 1998 |
Botryomycosis in a child with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Antibiotics, Antitubercular; Cephalexin; Cephalosporins; Child; Female; Humans; Immunocompromised Host; Lymph Nodes; Pathology; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome | 2000 |
Mutations in DnaA protein suppress the growth arrest of acidic phospholipid-deficient Escherichia coli cells.
Topics: Amino Acid Substitution; Bacterial Proteins; Cell Division; Cephalexin; Chromosomes, Bacterial; DNA Replication; DNA-Binding Proteins; DNA, Bacterial; Escherichia coli; Flow Cytometry; Hydrogen-Ion Concentration; Origin Recognition Complex; Phospholipids; Plasmids; Protein Structure, Tertiary; Rifampin; Sequence Deletion; Suppression, Genetic; Transformation, Bacterial; Viral Proteins | 2001 |
Roles of Escherichia coli histone-like protein HU in DNA replication: HU-beta suppresses the thermosensitivity of dnaA46ts.
Topics: Bacterial Proteins; Blotting, Western; Cell Division; Cephalexin; Cephalosporins; Chromosomes, Bacterial; DNA Replication; DNA-Binding Proteins; DNA, Bacterial; Enzyme Inhibitors; Escherichia coli; Escherichia coli Proteins; Flow Cytometry; Hot Temperature; Mutation; Phenotype; Rifampin | 2001 |
Synchronous replication initiation of the two Vibrio cholerae chromosomes.
Topics: Centrifugation, Density Gradient; Cephalexin; Chromosomes, Bacterial; DNA Replication Timing; Escherichia coli; Flow Cytometry; Isotope Labeling; Rifampin; Time Factors; Vibrio cholerae | 2004 |
[Immunomodulating, antioxidant and hepatoprotective effects of immobilized dosage forms of rifampicin and cephalexin].
Topics: Adjuvants, Immunologic; Animals; Anti-Bacterial Agents; Antioxidants; Cephalexin; Dose-Response Relationship, Drug; Drug Carriers; Drug Evaluation, Preclinical; Erythrocytes; Hepatocytes; Injections, Intramuscular; Liver; Lymphocyte Count; Rats; Rats, Wistar; Rifampin; Spleen; Staphylococcus aureus | 2004 |